The efficacy and safety of mirvetuximab soravtansine for the treatment of recurrent ovarian cancer: an update systematic review and meta-analysis
Abstract Introduction This meta-analysis aims to evaluate the efficacy and safety of mirvetuximab soravtansine (MIRV) in patients with recurrent ovarian cancer, with particular emphasis on those with platinum-resistant disease. Method A comprehensive search of PubMed, EMBASE, and the Cochrane Librar...
Gardado en:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer
2025-11-01
|
| Series: | Discover Oncology |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1007/s12672-025-03933-x |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|